United Therapeutics | UTHR - Stock


United Therapeutics reported $178.3M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Amarin USD 183.58M 12.32M Mar/2026
Ardelyx USD 128.02M 110.29M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Bayer EUR 12.34B 3M Dec/2025
BioCryst Pharmaceuticals USD 5.98M 587K Mar/2026
Biogen USD 1.95B 219.1M Mar/2026
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Emergent BioSolutions USD 328.9M 25.2M Dec/2023
Esperion Therapeutics USD 104.21M 915K Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Halozyme Therapeutics USD 155.47M 21.01M Mar/2026
Insmed USD 132.91M 841K Mar/2026
Ionis Pharmaceuticals USD 5.56M 4.49M Mar/2026
J&J USD 14.58B 392M Mar/2026
Lexicon Pharmaceuticals USD 276K 5K Mar/2026
Moderna USD 146M 7M Mar/2026
Omeros USD 712K 266K Sep/2021
Pfizer USD 10.67B 13M Mar/2026
PTC Therapeutics USD 75.57M 4.08M Mar/2026
Regeneron Pharmaceuticals USD 3.1B 97.2M Mar/2026
Sarepta Therapeutics USD 1B 86.37M Mar/2026
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
United Therapeutics USD 178.3M 4.8M Mar/2026
Vertex Pharmaceuticals USD 1.77B 79.9M Mar/2026